机构：[1]Department of Urology, Fudan UniversityShanghai Cancer Hospital, China[2]Department of Oncology, JiangSu CancerHospital, Nanjing, China[3]Department of Urology, Huadong Hospital,Fudan University, Shanghai, China[4]Department of Urology, Shanghai ChanghaiHospital, Second Military Medical University,Shanghai, China[5]Department of Urology, Cancer Institute(Hospital), Peking Union Medical College andChinese Academy of Medical Sciences,Beijing, China[6]Department of Urology, the Second AffiliatedHospital, Zhejiang University, School ofMedicine, Hangzhou, China[7]Urology Center, Southwest Hospital, ThirdMilitary Medical University, Chongqing, China[8]Department of Urinary Surgery, SecondAffiliated Hospital of Soochow University,Suzhou, China[9]Department of Urology, Renji Hospital, Schoolof Medicine, Shanghai Jiao Tong University,Shanghai, China[10]Department of Urology, Peking UniversityFirst Hospital and Institute of Urology, PekingUniversity, National Urological Cancer, Beijing,China[11]Department of Urology, Tongji Hospital,Tongji Medical College, Huazhong Universityof Science and Technology Wuhan, China华中科技大学同济医学院附属同济医院[12]Department of Urology, First AffiliatedHospital, School of Medicine, ZhejiangUniversity, Hangzhou, China[13]Janssen Research & Development, Beijing,China[14]Janssen Research & Development, Beerse,Belgium[15]Department of Urology, Fudan UniversityShanghai Cancer Center, Shanghai, China
第一作者机构：[1]Department of Urology, Fudan UniversityShanghai Cancer Hospital, China
推荐引用方式(GB/T 7714)：
Dingwei Ye,Qing Zou,Zhongquan Sun,et al.Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer[J].BJU INTERNATIONAL.2015,116:9-9.
APA：
Dingwei Ye,Qing Zou,Zhongquan Sun,Yinghao Sun,Changling Li...&DingweiYe.(2015).Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer.BJU INTERNATIONAL,116,
MLA：
Dingwei Ye,et al."Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer".BJU INTERNATIONAL 116.(2015):9-9
